Merck KGaA (MKKGY)
Data as of August 11, 2026 · Drug Manufacturers - Specialty & Generic
Stockbruh grade: Mixed 3/5 metrics rated Sunny
What does Merck KGaA do?
MERCK, headquartered in Darmstadt, Germany, is a leading global company operating in healthcare, life science, and electronics. They develop and market prescription drugs for various areas including neurology, immunology, and oncology. They also provide research tools and services for labs and offer solutions for industries like automotive and cosmetics. 💊🔬.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛈️ Weak | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ⛈️ Weak | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $33.29 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Returns have been below average recently — worth reviewing valuation carefully before investing. Sign up free to see the full Stockbruh valuation breakdown.
How the business works
MERCK, headquartered in Darmstadt, Germany, is a leading global company operating in healthcare, life science, and electronics. They develop and market prescription drugs for various areas including neurology, immunology, and oncology. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth has been challenging recently. Revenue or earnings are showing weak trends. Sign up free to see the full picture including forward projections.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.